These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6168125)

  • 41. [The treatment requiring heart rhythm disorders in ambulatory patients].
    Schöneberger A
    Schweiz Med Wochenschr; 1981 Nov; 111(45):1678-84. PubMed ID: 7313632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 43. [Continuous electrocardiographic recording. Clinical, diagnostic and therapeutic value].
    Coumel P; Attuel P; Mugica J; Slama R; Bouvrain Y
    Arch Mal Coeur Vaiss; 1975 Sep; 68(9):941-52. PubMed ID: 55107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficiency of antiarrhythmic therapy and resistance to it in patients with malignant ventricular tachyarrhythmias: formulation of prognosis].
    Nesterenko LIu; Bakalov SA; Krutanov IB; Maĭkov EB; Mazygula EP; Soboleva VA; Pasha SP; Sergienko VB; Golitsyn SP
    Ter Arkh; 1999; 71(9):70-6. PubMed ID: 10553631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 46. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of ergometric testing in the clinical evaluation of arrhythmia].
    Tullio D; Valerio A
    Minerva Cardioangiol; 1994 Mar; 42(3):85-96. PubMed ID: 8022552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Circadian variations in the frequency of arrhythmia and quantitative analysis of rhythm disturbances].
    Steinbach K; Eder A; Glogar D; Joskowicz G; Weber H
    Acta Med Austriaca; 1978; 5(4-5):132-4. PubMed ID: 91299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ambulatory management of ventricular arrhythmias.
    Morganroth J
    Med Times; 1980 Jan; 108(1):42-6. PubMed ID: 7374399
    [No Abstract]   [Full Text] [Related]  

  • 51. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of an antiarrhythmic drug on frequency of ventricular extrasystoles and bursts].
    Bussmann WD; Müller E; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1973; 79():999-1001. PubMed ID: 4133378
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiac and antiarrhythmic effects of imipramine in patients with ventricular arrhythmias.
    Giardina EG
    Biomed Pharmacother; 1984; 38(3):128-30. PubMed ID: 6478051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anti-arrhythmia therapy--ECG cosmetics or therapeutic requirement?].
    Gülker H
    Fortschr Med; 1988 Nov; 106(34):14-5. PubMed ID: 3209173
    [No Abstract]   [Full Text] [Related]  

  • 55. [Ventricular rhythm disorders in congestive myocardiopathy].
    Leclerq JF; Maisonblanche P; Cauchemez B; Attuel P; Coumel P
    Arch Mal Coeur Vaiss; 1984 Aug; 77(8):937-45. PubMed ID: 6207793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy of ventricular arrhythmias].
    Frohner K
    Wien Med Wochenschr; 1984 Oct; 134(19-20):448-57. PubMed ID: 6516421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical trial of a new antiarrhythmic agent and study of its blood levels].
    Desruelles J; Cuingnet E; Gérard A; Ducatillon P; Waucampt JJ
    Arch Mal Coeur Vaiss; 1968 Jun; 61(6):869-78. PubMed ID: 4175924
    [No Abstract]   [Full Text] [Related]  

  • 58. [Digoxin in the treatment of patients with ventricular disorders of cardiac rhythm].
    Kurbanov RD; Kiiakbaev GK; Khodzhanova TR
    Kardiologiia; 1985 Jul; 25(7):74-7. PubMed ID: 2414507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Arrhythmias, excitation and conduction abnormalities in chronic kidney failure with hemodialysis].
    Taniguchi K; Itoh H; Yamaguchi T
    Nihon Rinsho; 1992 Jan; 50 Suppl():676-83. PubMed ID: 1374488
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of 24-hour long-term electrocardiogram and exercise testing in the detection of ventricular arrhythmias (author's transl)].
    Tiso B; Fitscha P; Meisner W; Spitzer D
    Z Kardiol; 1982 May; 71(5):365-9. PubMed ID: 6180563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.